T1	p 32 41	anxiety :
T2	p 248 325	92 outpatients affected by generalized anxiety disorders for at least 1 month
T3	p 374 385	47 patients
T4	p 888 962	Seventy-eight patients completed the first period and 75 the whole study .
T5	i 19 28	ketazolam
T6	i 162 201	ketazolam ( 15 and 30 mg ) with placebo
T7	i 405 414	ketazolam
T8	i 433 440	placebo
T9	i 701 710	ketazolam
T10	i 1148 1155	placebo
T11	i 1206 1215	ketazolam
T12	i 1565 1572	placebo
T13	o 32 41	anxiety :
T14	o 545 590	total Hamilton Anxiety Rating Scale ( HAM-A )
T15	o 815 834	Italian HAM-A scale
T16	o 846 887	4-point scale ( patient 's assessment ) .
T17	o 991 1015	percentage of responders
T18	o 1179 1190	HAM-A score
T19	o 1392 1405	4-point scale
T20	o 1518 1530	Tolerability
T21	o 1619 1636	severe headache .